Genotype/phenotype correlations for coagulation factor XIII: Specific normal polymorphisms are associated with high or low factor XIII specific activity

Blood

Volumn 93, Issue 3, 1999, Pages 897-905

  Anwar, Rashida ^a   Gallivan, Louise ^a   Edmonds, Stuart D ^a   Markham, Alexander F ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 13A; LEUCINE; PHENYLALANINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; RECURRENT ABORTION; THROMBOSIS;

EID: 0032904240     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.3.897     Document Type: Article

References (36)

1. Wisen O, Gardlund B: Hemostasis in Crohn's disease: Low FXIII levels in active disease. Scand J Gastroenterol 23:961, 1988
2. Suzuki R, Toda H, Takamura Y: Dynamics of blood coagulation factor XIII in ulcerative colitis and preliminary study of the factor XIII concentrate. Blut 59:162, 1989
3. van Wersch JWJ, Peters C, Ubachs JMH: Coagulation factor XIII in plasma of patients with benign and malignant gynaecological tumours. Eur J Clin Chem Clin Biochem 32:681, 1994
4. Johnson GVW, Cox TM, Lockhart JP, Zinnerman MD, Miller ML, Powers RE: Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res 751:323, 1997
5. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D: Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Medicine 3:797, 1997
6. Barry ELR, Mosher DF: Factor XIIIa-mediated cross-linking of fibronectin in fibroblast cell-layers: Cross-linking of cellular and plasma fibronectin and of amino-terminal fibronectin fragments. J Biol Chem 264:4179, 1989
7. Sane DC, Moser TL, Pippen AMM, Parker CJ, Achyuthan KE, Greenberg CS: Vitronectin is a substrate for transglutaminases. Biochem Biophys Res Commun 157:115, 1988
8. Paye M, Nusgens B, Lapiere CM: Factor XIII of blood coagulation decreases the susceptibility of collagen precursors to proteolysis. Biochim Biophys Acta 1073:437, 1991
9. Borth W, Chang V, Bishop P, Harpel PC: Lipoprotein(a) is a substrate for factor XIIIa and tissue transglutaminase. J Biol Chem 266:18149, 1991
10. Duckert F, Jung E, Shmerling DH: A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilising factor deficiency. Thrombosis, Diathesis Haemorrhage 5:179, 1960
11. Miloszewski KJA, Losowsky MS: Fibrin stabilisation and factor XIII deficiency, in Francis L (ed): Fibrinogen, Fibrin Stabilisation and Fibrinolysis. Chichester, UK, Ellis Horwood, 1988, p 175
12. Aeshlimann D, Paulsson M: Transglutaminases: Protein cross-linking enzymes in tissues and body fluids. Thromb Haemost 71:402, 1994
13. Schwartz ML, Pizzo SV, Hill RL, McKee PA: Human factor XIII from plasma and platelets. J Biol Chem 248:1395, 1973
14. Takagi T, Doolittle RF: Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin. Biochemistry 13:750, 1974
15. Lorand L, Losowsky MS, Miloszewski KJM: Human factor XIII fibrin stabilising factor. Prog Hemost Thromb 5:245, 1980
16. Anwar R, Stewart AD, Miloszewski KJA, Losowsky MS, Markham AF: Molecular basis of inherited factor XIII deficiency: Identification of multiple mutations provides insights into protein function. Br J Haematol 91:728, 1995
17. Anwar R, Miloszewski KJA, Markham AF: Identification of a large deletion, spanning exons 4 to 11 of the human FXIIIA gene, in a factor XIII-deficient family. Blood 91:149, 1998
18. Anwar R, Miloszewski KJA, Markham AF: New splicing mutations in the human FXIIIA gene, each producing multiple mutant transcripts of varying abundance. Thromb Haemost 79:1151, 1998
19. Laki K, Lorand L: On the solubility of fibrin clots. Science 108:280, 1948
20. Muszbek L, Polgar J, Fesus L: Continuous determination of blood coagulation factor XIII in plasma. Clin Chem 31:35, 1985
21. Lee KN, Birckbichler PJ, Patterson MK: Calorimetric assay of blood coagulation FXIII in plasma. Clin Chem 34:906, 1988
22. Slaughter TF, Achyuthan KE, Lai TS, Greenberg CS: A microtitre plate transglutaminase assay utilising 5(biotinamido) pentylamine as substrate. Anal Biochem 205:166, 1992
23. Song YC, Sheng DeQ, Taubenfeld SM, Matsueda GR: A microtitre assay for factor XIII using fibrinogen and biotinylcadaverine as substrates. Anal Biochem 223:88, 1994
24. Murdock PJ, Owens DL, Chitoli A, Hutton RA, Lee CA: Development and evaluation of ELISAs for FXIIIA and XIIIB subunits in plasma. Thromb Res 67:73, 1992
25. Shainoff JR, Estafanous FG, Yared JP, Dibello PM, Kottkemarchant K, Loop FD: Low FXIIIA levels are associated with increased blood loss after coronary-artery bypass-grafting. J Thorac Cardiovasc Surg 108:437, 1994
26. Wagner B, Seyfert UT, Gosse M, Wenzel E, Fickenscher K, Ruhl H-G: Determination of factor XIII activity by a new photometric assay in plasma and platelets of healthy blood donors. Thromb Res 74:169, 1994
27. Suzuki K, Henke J, Iwata M, Henke L, Tsuji H, Fukunaga T, Ishimoto G, Szekelyi M, Ito S: Novel polymorphisms and haplotypes in the human coagulation factor XIIIA subunit gene. Hum Genet 98:393, 1996
28. Yee VC, Pedersen LC, Trong IL, Bishop PD, Stenkamp RE, Teller DC: Three-dimensional structure of a transglutaminase: Human blood coagulation factor XIII. Proc Natl Acad Sci USA 91:7296, 1994
29. Francis C, Marder VJ: Rapid formation of large molecular weight α-polymers in cross-linked fibrin induced by high factor XIII concentrations. J Clin Invest 80:1459, 1987
30. Kohler HP, Stichland MH, OsseiGerning N, Carter A, Mikkola H, Grant PJ: Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 79:8, 1998
31. Lunghi B, lacoviello L, Gemmati D, Dilasio MG, Castoldi E, Pinotti M, Castaman G, Redaelli R, Mariani G, Marchetti G, Bernardi F: Detection of new polymorphic markers in the factor V gene -association with factor V levels in plasma. Thromb Haemost 75:45, 1996
32. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, Zepponi E, Ursicino N, Chiarotti F, Mariani G: Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vase Biol 16:72, 1996
33. Dawson S, Hamsten A, Wiman B, Henney A, Humphries S: Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity. ArteriosclerThromb 11:183, 1991
34. Scarabin PY, Bara L, Ricard S, Poirier O, Cambou JP, Arveiler D, Luc G, Evans AE, Samama MM, Cambien F: Genetic variation at the beta-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction - the ECTIM study. Arterioscler Thromb 13:886, 1993
35. Poort SR, Rosendaal FR, Reitsma PH, Bettina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698, 1996
36. Kangsadalampai S, Board PG: The Val34Leu polymorphism in the A subunit of coagulation factor XIII contributes to the large normal range in activity and demonstrates that the activation peptide plays a role in catalytic activity. Blood 92:2766, 1998